Loading insider details...
Beta
Latest Form 4 (Aug 13, 2026): Sale of 50,012 TAK shares, $855.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Sale | 50,012 | $855.2K |
| Jul 6, 2026 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/Award | 43,886 | n/a |
| Jun 15, 2026 | Aura Biosciences, Inc. (AURA) | Grant/Award | 15,000 | n/a |
| Apr 28, 2026 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/Award | 64,988 | n/a |
| Apr 2, 2025 | Aura Biosciences, Inc. (AURA) | Grant/Award | 21,000 | n/a |
| Jun 4, 2024 | Fusion Pharmaceuticals Inc. (FUSN) | Disposition to Issuer | 34,000 | n/a |